Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction

BACKGROUND:The observed incidence of type 2 myocardial infarction (T2MI) is expected to increase with the implementation of increasingly sensitive cTn assays. However, it remains to be determined how to diagnose, risk-stratify, and treat patients with T2MI. We aimed to discriminate and risk-stratify...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2020-10, Vol.142 (16), p.1532-1544
Hauptverfasser:	Horiuchi, Yu, Wettersten, Nicholas, Patel, Mitul P., Mueller, Christian, Neath, Sean-Xavier, Christenson, Robert H., Morgenthaler, Nils G., McCord, James, Nowak, Richard M., Vilke, Gary M., Daniels, Lori B., Hollander, Judd E., Apple, Fred S., Cannon, Chad M., Nagurney, John T., Schreiber, Donald, deFilippi, Christopher, Hogan, Christopher, Diercks, Deborah B., Headden, Gary, Limkakeng, Alexander T., Anand, Inder, Wu, Alan H.B., Ebmeyer, Stefan, Jaffe, Allan S., Peacock, W. Frank, Maisel, Alan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - metabolism Female Humans Male Middle Aged Myocardial Infarction - diagnosis Prognosis Prospective Studies Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!